We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

97 hedge funds and large institutions have $359M invested in Olema Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

408% more call options, than puts

Call options by funds: $1.16M | Put options by funds: $229K

154% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 13

116% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 19

28% more funds holding

Funds holding: 76 → 97 (+21)

2.5% more ownership

Funds ownership: 92.88% → 95.38% (+2.5%)

65% less capital invested

Capital invested by funds: $1.01B → $359M (-$653M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
97
Holders Change
+21
Holders Change %
+27.63%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
33
Reduced
13
Closed
19
Calls
$1.16M
Puts
$229K
Net Calls
+$935K
Net Calls Change
+$389K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$15.5M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$11.6M
3
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$10.8M
5
Morgan Stanley
Morgan Stanley
New York
+$10.5M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$22.3M
2
CAM
Cormorant Asset Management
Massachusetts
-$18.7M
3
VA
VR Adviser
New York
-$14.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$12.3M
5
FCMI
Foresite Capital Management IV
California
-$9.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
101
Ameriprise
Minnesota
– -$5.82M -210,926 Closed
ACP
102
Acuta Capital Partners
California
– -$4.15M -150,500 Closed
PAMS
103
Pictet Asset Management (Switzerland)
Switzerland
– -$4.14M -150,133 Closed
Russell Investments Group
104
Russell Investments Group
United Kingdom
– -$3.46M -125,383 Closed
Renaissance Technologies
105
Renaissance Technologies
New York
– -$2.7M -97,900 Closed
FAM
106
Fred Alger Management
New York
– -$2.56M -92,785 Closed
MFS
107
Mirabella Financial Services
United Kingdom
– -$714K -25,920 Closed
Man Group
108
Man Group
United Kingdom
– -$400K -14,500 Closed
SG Americas Securities
109
SG Americas Securities
New York
– -$387K -14,060 Closed
M&T Bank
110
M&T Bank
New York
– -$296K -10,735 Closed
VOYA Investment Management
111
VOYA Investment Management
Georgia
– -$266K -9,650 Closed
Invesco
112
Invesco
Georgia
– -$228K -8,263 Closed
EWA
113
Evolution Wealth Advisors
Florida
– -$3K -126 Closed
C
114
Covestor
United Kingdom
– +$311 +15 New
1 2 3 4
5

OLMA Hedge Fund Activity: Q4 2021 in Review

97 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q4 2021, worth a combined $359M — down 65% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new OLMA positions and 19 closed out — a net gain of 22 holders — while 33 added to existing stakes and 13 trimmed.

The largest buyer was BVF Inc, adding an estimated $15.5M. The largest seller was OrbiMed, exiting entirely with an estimated $22.3M sold.

  • 97 institutional investors held Olema Pharmaceuticals (OLMA) as of Q4 2021, up from 76 in Q3 2021.
  • Funds reported $359M of Olema Pharmaceuticals stock for Q4 2021, down 65% quarter-over-quarter.
  • 41 funds opened new Olema Pharmaceuticals positions in Q4 2021 and 19 closed out, a net change of +22 holders.
  • The largest Olema Pharmaceuticals buyer in Q4 2021 was BVF Inc, an estimated $15.5M added.
  • The largest Olema Pharmaceuticals seller in Q4 2021 was OrbiMed, an estimated $22.3M sold.

Based on aggregated 13F filings for Q4 2021.